Novo Nordisk ends kidney disease trial, books $816 million impairment in Q2
COPENHAGEN (Reuters) -Novo Nordisk said on Wednesday it would recognise an impairment loss of about...
COPENHAGEN (Reuters) -Novo Nordisk said on Wednesday it would recognise an impairment loss of about...
By Jonathan Stempel (Reuters) – Jho Low, the fugitive Malaysian financier, will forfeit more than...
By David Shepardson WASHINGTON (Reuters) -Volkswagen said on Wednesday it was recalling over 307,000 vehicles...
(Reuters) -Amazon.com Inc hit $2 trillion in market value for the first time on Wednesday,...
By Chibuike Oguh NEW YORK (Reuters) – Shares of Nvidia were up over 5% on...
By Jason Lange WASHINGTON (Reuters) – U.S. voters see Republican presidential candidate Donald Trump as...
By Chuck Mikolajczak and Lewis Krauskopf NEW YORK (Reuters) – Investors are gearing up for...
LAS VEGAS (Reuters) – Albemarle, the world’s largest lithium producer, is concerned about current prices...
By Curtis Williams HOUSTON(Reuters) – A shortage of skilled labor and nagging inflation from strong...
By Jack Queen WASHINGTON (Reuters) -Lawyers for Hunter Biden, the son of U.S. President Joe...